Cardiac amyloidosis
Cardiac MRI is a useful tool to diagnose amyloidosis. T1 mapping has become a mainstay, both native and ECV measurements. ECV measurement can now help quantify the amyloidosis burden and may help guide treatment based on how the ECV responds to specific treatment measures.
RVoTo involvement in HCM is uncommon but diagnosing it may change the management plan and prognosis